ASTELLAS PHARMA US
Sign in to add to a watchlist →
lobbying_client · US · canonical: astellas pharma us · 1 alias · 0 outbound · 8 inbound
Related entities (9)
Same brand-name cluster — possible parent, subsidiary, PAC, or lobbying registration. Surfaced via head-token match (e.g. every "AMAZON …" org) and pg_trgm similarity for variant spellings. Not yet asserted as parent/child edges; treat as a navigation aid.
- ASTELLAS US LLCcorporation · head-token 0.85
- ASTELLAS US LLC PAC (ASTELLAS PAC)pac · head-token 0.85
- ASTELLAS PHARMA US, INClobbying_client · head-token 0.85
- ASTELLAS PHARMA US, INC.lobbying_client · head-token 0.85
- ASTELLAS PHARMA US INC.employer · head-token 0.85
- ASTELLAS PHARMA US, INC.lobbying_firm · head-token 0.85
- ASTELLAS PHARMA US, INC.lobbying_firm · head-token 0.85
- ALVOGEN, PHARMA US, INC.lobbying_client · trigram 0.42
- TIBER CREEK GROUP ON BEHALF OF ASTELLAS PHARMA US, INC.lobbying_client · trigram 0.40
Timeline
Every typed-graph event involving this entity, newest first. Each row is one edge in the influence graph; the inline strip under the row shows the counterpart's own context (a bill's latest action, a hearing's chamber + date, a filing's form type + filed date, a clip's source + excerpt) so the timeline reads like a Wikipedia citation rail.
- 2026-05-23 · lobbied by Brett Meeks · lda_lobbyist_client
- 2026-05-23 · lobbied by Laura Kemper · lda_lobbyist_client
- 2026-05-23 · lobbied by John R Ray · lda_lobbyist_client
- 2026-05-23 · lobbied by David Rudloff · lda_lobbyist_client
- 2026-05-23 · lobbied by Keith Studdard · lda_lobbyist_client
- 2026-05-23 · lobbied by John Herzog · lda_lobbyist_client
- 2026-05-23 · lobbied by Jeffrey J Kimbell · lda_lobbyist_client
- 2026-05-23 · lobbied by Kenneth Lee Hodge · lda_lobbyist_client
Lobbying disclosures — as CLIENT (1)
Filings where this org hired a lobbying firm. Income + expenses come from the LDA disclosure.
| Posted | Filing | Year | Period | Registrant (lobbying firm) | Income | Expenses |
|---|---|---|---|---|---|---|
| 2026-04-20 | 1st Quarter - Report | 2026 | first_quarter | 46038 | $40,000 | — |
Connected on the graph
8 typed relationships in the influence graph — 8 inbound, 0 outbound, grouped by type.
lobbied for (8)
| date | dir | entity | amount | role | source |
|---|---|---|---|---|---|
| — | ← | Brett Meeks | — | lda_lobbyist_client | |
| — | ← | Laura Kemper | — | lda_lobbyist_client | |
| — | ← | John R Ray | — | lda_lobbyist_client | |
| — | ← | David Rudloff | — | lda_lobbyist_client | |
| — | ← | Keith Studdard | — | lda_lobbyist_client | |
| — | ← | John Herzog | — | lda_lobbyist_client | |
| — | ← | Jeffrey J Kimbell | — | lda_lobbyist_client | |
| — | ← | Kenneth Lee Hodge | — | lda_lobbyist_client |
Aliases (1)
| source | id | name at source | jurisdiction | confidence | linked by | linked at |
|---|---|---|---|---|---|---|
| lda_client | 153900 | ASTELLAS PHARMA US | US | gold | sync_canonical_entities |